No overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 276, Issue 4 39-4, 1999, Pages

  Wiest, Reiner ^a   Shah, Vijay ^a,b,c,d   Sessa, William C ^b   Groszmann, Roberto J ^a,c  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Endothelial nitric oxide synthase; Superior mesenteric artery; Vasodilation

Indexed keywords

METHOXAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTICLE; ENDOTHELIUM; MALE; MESENTERY BLOOD VESSEL; NONHUMAN; OXYGEN TENSION; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SPLANCHNIC BLOOD FLOW; VASOCONSTRICTION; VASODILATATION;

EID: 0032938259     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.276.4.g1043     Document Type: Article

References (55)

1. Albillos, A., L. Colombato, R. Enriquez, O. Ng, E. Sikuler, and R. Groszmann. Sequence of morphological and hemodynamic changes of gastric microvessels in portal hypertension. Gastroenterology 102: 2066-2070, 1992.
2. Bhagat, K., and P. J. Vallance. Induction of nitric oxide synthase in humans, in vivo: endothelial nitric oxide synthase masquerading as inducible nitric oxide synthase (Abstract). Circulation: A4069, 1997.
3. Bosch, J., M. Navasa, J. Garcia-Pagan, A. DeLacy, and J. Rodes. Portal hypertension (Review). Med. Clin. North Am. 73: 931-953, 1989.
4. Brownlee, R., and B. Langille. Arterial adaptations to altered blood flow. Can. J. Physiol. Pharmacol. 69: 978-983, 1991.
5. Buga, G., M. Gold, J. Fukuto, and L. Ignarro. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17: 187-193, 1991.
6. Cahill, P., C. Foster, E. Redmond, C. Gingalewski, Y. Wu, and J. Sitzmann. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology 22: 598-606, 1995.
7. Campillo, B., P. Chabrier, G. Pelle, S. Sediame, G. Atlan, P. Fouet, and S. Adnot. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 22: 1423-1429, 1995.
8. Castro, A., W. Jimenez, J. Claria, J. Ros, J. Martinez, M. Bosch, V. Arroyo, J. Piulates, F. Rivera, and J. Rodes. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology 18: 367-372, 1993.
9. Chojkier, M., and R. Groszmann. Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am. J. Physiol. 240 (Gastrointest. Liver Physiol. 3): G371-G375, 1981.
10. Claria, J., W. Jimenez, J. Ros, M. Asbert, A. Castro, V. Arroyo, F. Rivera, and J. Rodes. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 15: 343-349, 1992.
11. Colombato, L., A. Albillos, and R. Groszmann. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal hypertensive rats. Hepatology 15: 323-328, 1992.
12. Cooke, J., J. Rossitch, E. N. Andon, J. Loscalzo, and V. Dzau. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J. Clin. Invest. 88: 1663-1671, 1991.
13. Farrell, G., A. Koltai, and M. Murray. Source of raised serum estrogens in male rats with portal bypass. J. Clin. Invest. 81: 221-228, 1988.
14. Fernandez, M., J. Garcia-Pagan, M. Casadevall, C. Bernadich, C. Piera, B. Whittle, J. Pique, J. Bosch, and J. Rodes. Evidence against a role for inducible nitric oxide synthase in the hyperdyamic circulation of portal-hypertensive rats. Gastroenterology 108: 1487-1495, 1995.
15. Fernandez-Rodriguez, C., J. Prieto, J. Quiroga, J. Zozoya, A. Andrade, M. Nunez, B. Sangro, and J. Penas. Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion. Hepatology 21: 35-40, 1995.
16. Fleming, I., J. Bauersachs, and R. Buse. Calcium-dependent and calcium-independent activation of the endothelial NO synthase (Review). J. Vasc. Res. 34: 165-174, 1997.
17. Förstermann, U., J. P. Boissel, and H. Kleinert. Expressional control of the constitutive isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 12: 773-790, 1998.
18. Gadano, A., P. Sogni, S. Yang, S. Cailmail, R. Moreau, P. Nepveux, D. Couturier, and D. Lebrec. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats. J. Hepatol. 26: 678-686, 1997.
19. Garcia-Tsao, G., A. Albillos, G. Barden, and A. West. Bacterial translocation in acute and chronic portal hypertension. Hepatology 17: 1081-1085, 1993.
20. Guarner, C., G. Soriano, A. Tomas, O. Bulbena, M. Novella, J. Balanzo, F. Vilardell, M. Mourelle, and S. Moncada. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 18: 1139-1143, 1993.
21. Hecker, M., A. Mulsch, E. Bassenge, and R. Busse. Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H828-H833, 1993.
22. Hori, N. Direct evidence for increased functional activity of eNOS in superior mesenteric arterial beds of portal hypertensive rats (Abstract). Hepatology 24: A749, 1996.
23. Hori, N., H. Takahashi, T. Okanoue, Y. Sawa, T. Mori, S. Takami, M. Yashimura, and K. Kashima. Augmented endogenus nitric oxide production in partial portal vein-ligated rats. Clin. Exp. Pharmacol. Physiol. 22: 506-511, 1995.
24. John, S. J., P. Martin, D. Xu, M. Ohara, and R. Schrier. Effect of circulating substances known to be increased in cirrhosis on endothelial nitric oxide synthase (eNOS) mRNA (Abstract). J. Am. Soc. Nephrol. 7: A1619, 1996.
25. Kiel, J. W., V. Pitts, J. N. Benoit, D. N. Granger, and A. D. Shepherd. Reduced vascular sensitivity to norepinephrine in portal hypertensive rats. Am. J. Physiol. 248 (Gastrointest. Liver Physiol. 11): G192-G195, 1985.
26. Kuchan, M., and J. Frangos. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am. J. Physiol. 266 (Cell Physiol. 35): C628-C636, 1994.
27. Lantin-Hermoso, R., C. Rosenfeld, I. Yuhanna, Z. German, Z. Chen, and P. Shaul. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am. J. Physiol. 273 (Lung Cell. Mol. Physiol. 17): L119-L126, 1997.
28. Liao, J. K., J. J. Zulueta, F. S. Yu, H. B. Peng, C. G. Cote, and P. M. Haussoun. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J. Clin. Invest. 96: 2661-2666, 1995.
29. Lopez-Talavera, J., G. Cadelina, J. Olchowski, W. Merrill, and R. J. Groszmann. Thalidomide inhibits tumor necrosis factor-α, decreases nitric oxide synthesis and ameliorates the hyperdynamic circulatory syndrome in portal hypertensive rats. Hepatology 23: 1616-1621, 1996.
30. Lopez-Talavera, J., A. Levitzki, M. Martinez, A. Gazit, R. Esteban, and J. Guardia. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites. J. Clin. Invest. 100: 664-670, 1997.
31. Lopez-Talavera, J., W. Merrill, and R. Groszmann. Tumor necrosis factor a: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 108: 761-767, 1995.
32. Martin, P., D. Xu, M. Niederberger, A. Weigert, P. Tsai, J. St John, P. Gines, and R. Schrier. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am. J. Physiol. 270 (Renal Physiol. 39): F494-F499, 1996.
33. McGregor, D. The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric vessels of the rat. J. Physiol. (Lond.) 177: 21-30, 1965.
34. 2+ signaling of vascular endothelial cells: effect of shear stress and ATP. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H1698-H1707, 1991.
35. Moncada, S., R. Palmer, and E. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology (Review). Pharmacol. Rev. 43: 109-142, 1991.
36. Morales-Ruiz, M., W. Jimenez, D. Perez-Sala, J. Ros, A. Leivas, S. Lamas, F. Rivera, and V. Arroyo. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 24: 1481-1486, 1996.
37. Nadaud, S., M. Philippe, J. Arnal, J. Michel, and F. Soubrier. Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ. Res. 79: 857-863, 1996.
38. Niederberger, M., P. Gines, P. Martin, P. Tsai, K. Morris, I. McMurtry, and R. Schrier. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 24: 947-951, 1996.
39. Niederberger, M., P. Martin, P. Gines, K. Morris, P. Tsai, D. Xu, I. McMurty, and R. Schrier. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 109: 1624-1630, 1995.
40. Pizcueta, M., J. Pique, J. Bosch, B. Whittle, and S. Moncada. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br. J. Pharmacol. 105: 184-190, 1992.
41. Ranjan, V., Z. Xiao, and S. Diamond. Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H550-H555, 1995.
42. Reichen, J. Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension. Hepatology 11: 1066-1078, 1990.
43. Rosenkranz-Weiss, P., W. Sessa, S. Milstien, S. Kaufman, C. Watson, and J. Pober. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J. Clin. Invest. 93: 2236-2243, 1994.
44. Rubanyi, G., J. Romero, and P. Vanhoutte. Flow-induced release of endothelium-derived relaxing factor. Am. J. Physiol. 250 (Heart Circ. Physiol. 19): H1145-H1149, 1986.
45. Schrier, R., V. Arroyo, M. Bernardi, M. Epstein, J. Henriksen, and J. Rodes. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention. Hepatology 8: 1151-1157, 1988.
46. Sessa, W. The nitric oxide synthase family of proteins. J. Vasc. Res. 31: 131-143, 1994.
47. Sessa, W., K. Pritchard, N. Seyedi, J. Wang, and T. Hintze. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 74: 349-353, 1994.
48. Shah, V., F. Haddad, G. Garcia-Cardena, J. Frangos, A. Mennone, R. Groszmann, and W. Sessa. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J. Clin. Invest. 100: 2923-2930, 1997.
49. Sieber, C., and R. Groszmann. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am. J. Physiol. 262 (Gastrointest. Liver Physiol. 25): G996-G1001, 1992.
50. Sieber, C., J. Lopez-Talavera, and R. Groszmann. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 104: 1750-1754, 1993.
51. Sikuler, E., D. Kravetz, and R. Groszmann. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am. J. Physiol. 248 (Gastrointest. Liver Physiol. 11): G618-G625, 1985.
52. Smiesko, V., J. Kozik, and S. Dolezel. Role of endothelium in the control of arterial diameter by blood flow. Blood Vessels 22: 247-251, 1985.
53. Takahashi, M., T. Ishida, O. Traub, M. Corson, and B. Berk. Mechanotransduction in endothelial cells: temporal signaling events in response to shear stress (Review). J. Vasc. Res. 34: 212-219, 1997.
54. G-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release. J. Pharmacol. Exp. Ther. 257: 1208-1215, 1991.
55. Vorobioff, J., J. E. Bredfeldt, and R. J. Groszmann. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am. J. Physiol. 244 (Gastrointest. Liver Physiol. 7): G52-G57, 1983.